Retropatellar fat pad-derived stem cells from older osteoarthritic patients have lesser differentiation capacity and expression of stemness genes

Cytotherapy

Volumn 16, Issue 5, 2014, Pages 599-611

  Chua, Kien Hui ^a   Zaman Wan Safwani, Wan Kamarul ^b   Hamid, Adila A ^a   Shuhup, Siti Khadijah ^a   Mohd Haflah, Nor Hazla ^a   Mohd Yahaya, Nor Hamdan ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Chondrogenesis; Osteoarthritis; Regenerative medicine; Retropatellar fat pad; Stem cells; Total knee replacement

Indexed keywords

ACP GENE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; ALP GENE; AP2 GENE; ARTICLE; ARTICULAR CARTILAGE; BONE DEVELOPMENT; BSP GENE; CARTILAGE DEGENERATION; CARTILAGE REGENERATION; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL KINETICS; CELL STRUCTURE; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GAPDH GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; JOINT DEGENERATION; KNEE OSTEOARTHRITIS; LPL GENE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NANOG3 GENE; NESTIN GENE; NUCLEOTIDE SEQUENCE; OCT4 GENE; OSC GENE; PPAR GAMMA GENE; PRIORITY JOURNAL; RETROPATELLAR FAT PAD; REX1 GENE; SOX9 GENE; TISSUE REGENERATION; CELL CULTURE; CYTOLOGY; FEMALE; FLOW CYTOMETRY; MALE; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS; PHYSIOLOGY; STEM CELL;

ADIPOSE TISSUE; ADULT; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; STEM CELLS;

EID: 84897965049     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.08.013     Document Type: Article

References (34)

1. Felson D.T. Osteoarthritis of the knee. NEngl J Med 2006, 354:841-848.
2. McAlindon T.E., LaValley M.P., Gulin J.P., Felson D.T. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000, 283:1469-1575.
3. Atkinson H.D., Ranawat V.S., Oakeshott R.D. Granuloma debridement and the use of an injectable calcium phosphate bone cement in the treatment of osteolysis in an uncemented total knee replacement. JOrthop Surg Res 2010, 5:29.
4. Maloney W.J. Management of osteolysis after total knee replacement. JBone Joint Surg Br 2010, 92-B(Suppl I):90-91.
5. Mobasheri A., Csaki C., Clutterbuck A., Rahmanzadeh M., Shakibaei M. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: application in cartilage repair and osteoarthritis therapy. Histol Histopathol 2009, 24:347-366.
6. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
7. Zandstra P.W., Nagy A. Stem cell bioengineering. Annu Rev Biomed Eng 2001, 3:275-305.
8. Hoffa A. Influence of adipose tissue with regard to the pathology of the knee joint. JAMA 1904, 12:795-796.
9. Vahlensieck M., Linneborn G., Schild H., Schmidt H.M. Hoffa's recess: incidence, morphology and differential diagnosis of the globular-shaped cleft in the infra-patellar fat pad of the knee on MRI and cadaver dissections. Eur Radiol 2002, 12:90-93.
10. Jurgens W.J., van Dijk A., Doulabi B.Z., Niessen F.B., Ritt M.J., van Miligen F.J., et al. Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy 2009, 11:1052-1064.
11. English A., Jones E.A., Corscadden D., Henshaw K., Chapman T., Emery P., et al. Acomparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. Rheumatology 2007, 46:1676-1683.
12. Wan Safwani W.K.Z., Makpol S., Santhapan S., Chua K.H. The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manupilation. Biotechnol Appl Biochem 2011, 58:261-270.
13. Hamid A.A., Idrus B.H.I., Saim A.B., Sathapan S., Chua K.H. Characterization of human adipose-derived stem cells and expression of chondrogenic genes during induction of cartilage differentiation. Clinics 2012, 67:1-8.
14. Zainuddin A., Chua K.H., Rahim N.A., Makpol S. Effect of experimental treatment on GAPDH mRNA expression as a housekeeping gene in human diploid fibroblasts. BMC Mol Biol 2010, 11:59.
15. Barbero A., Ploegert S., Heberer M., Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 2003, 48:1315-1325.
16. Tallheden T., Dennis J.E., Lennon D.P., Sjögren-Jansson E., Caplan A.I., Lindahl A. Phenotypic plasticity of human articular chondrocytes. JBone Joint Surg-Am 2003, 85A:93-100.
17. Gregory C.A., Singh H., Perry A.S., Prockop D.J. The Wnt signalling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. JBiol Chem 2003, 278:28067-28078.
18. Mitchell J.B., McIntosh K., Zvonic S., Garrett S., Floyd Z.E., Kloster A., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385.
19. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue. Stem Cells 2006, 4:1294-1301.
20. Fraser J.K., Wulur I., Alfonso Z., Hedrick M.H. Fat tissue: an underappreciated source of stem cell for biotechnology. Trends Biotechnol 2006, 24:150-154.
21. Michalik L., Auwerx J., Berger J.P., Chatterjee V.K., Glass C.K., Gonzalez FJ., et al. International Union of Pharmacology, LXI: peroxisome proliferator-activated receptors. Pharmacol Rev 2006, 58:726-741.
22. Mead J.R., Irvine S.A., Ramji D.P. Lipoprotein lipase: structure, function, regulation and role in disease. JMol Med 2002, 80:753-769.
23. Ding J., Ghali O., Lencel P., Broux O., Chauveau C., Devedjian J.C., et al. TNF-α and IL-1β inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci 2009, 84:499-504.
24. Monfoulet L., Malaval L., Aubin J.E., Rittling S.R., Gadeau A.P., Fricain JC., et al. Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing. Bone 2009, 46:447-452.
25. Caetano-Lopes J., Canhao H., Fonseca J.E. Osteoblasts and bone formation. Acta Reum Port 2007, 32:103-110.
26. Tsuchiya H., Kitoh H., Sugiura F., Ishiguro N. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 2003, 301:338-343.
27. Ikeda T., Kamekura S., Mabuchi A., Kou I., Seki S., Takato T., et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 2004, 50:3561-3573.
28. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling KW., et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997, 16:174-178.
29. Paul R., Haydon R.C., Cheng H., Ishikawa A., Nenadovich N., Jiang W., et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003, 28:755-763.
30. Roughley P., Martens D., Rantakokko J., Alini M., Mwale F., Antoniou J. The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage. Eur Cell Mater 2006, 11:1-7.
31. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., et al. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
32. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
33. Yamanaka S., Takahashi K. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
34. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.